aetherAI vs Proscia (2026)
Two digital pathology platforms that host algorithms as well as building them, competing in different home markets. aetherAI comes from Taiwan with deployments across major Asian institutions, spans anatomical pathology and haematology rather than one tumour type, and secured both a United States clearance and European certification for its image management platform in 2026, which is a real move toward global reach. Proscia has the deeper Western installed base, serving clinical laboratories and life sciences customers on the same infrastructure. For a laboratory outside Asia, Proscia is the lower friction deployment with local support. aetherAI is the more interesting record because of the haematology reach, and its dual certification means it should now be on shortlists it would not have appeared on a year ago.
- It spans two distinct domains rather than one tumour type, covering anatomical pathology and haematology, with training scale disclosed for the haematology product.
- The image management platform secured both a United States clearance and European certification in 2026, which is a genuine dual market position rather than a single market one.
- The platform hosts diagnostic algorithms rather than only running its own, so a laboratory gets infrastructure and applications from one vendor.
- Its platform manages and analyses whole slide data for clinical laboratories and life sciences customers at established scale, which is a deeper installed base in Western markets.
- The clinical laboratory and life sciences split means the same infrastructure serves diagnostic work and research contracts, spreading the investment.
- For a laboratory in North America or Europe, an established platform with local support and regulatory standing is a lower risk deployment.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. aetherAI and Proscia are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | aetherAI | Proscia |
|---|---|---|
| Primary category | Digital Pathology AI | Digital Pathology AI |
| Founded | 2016 | 2014 |
| Headquarters | Taipei, Taiwan | Philadelphia, Pennsylvania, United States |
| Website | aetherai.com | proscia.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index records no top capability grade for aetherAI on any axis it scores. Set against Proscia, aetherAI does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, AI Governance and Bias Disclosure and AI Liability and Recourse. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Proscia its top capability grade on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Set against aetherAI, Proscia grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose aetherAI or Proscia?
The AI Health Index grades Proscia higher than aetherAI on every axis that separates them, several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. aetherAI does not grade higher on any scored axis.
Where do aetherAI and Proscia differ most?
The widest separation the AI Health Index records between aetherAI and Proscia is on Model Supply Chain Disclosure, where aetherAI grades D and Proscia grades A. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do aetherAI and Proscia grade the same?
The AI Health Index grades aetherAI and Proscia the same on several axes, including AI Centrality, AI Governance and Bias Disclosure and AI Liability and Recourse. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have aetherAI and Proscia not disclosed?
At the last review, at least one of aetherAI and Proscia published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Digital Pathology AI page.
Read the regulatory footprint by market rather than by company, since both vendors hold different permissions in different jurisdictions and a product usable for diagnosis in one place may be research use only in another. aetherAI publishes no health privacy statement, business associate terms, hosting detail or subgroup analysis. Neither publishes pricing.
Staining and scanner variation between laboratories remains the largest uncontrolled variable for any algorithm hosted on either platform, and neither vendor imposes a published performance requirement on the third party algorithms it distributes.